SCHEMBL24259966

SCHEMBL24259966

Nc1ccc(O)c(C23CC4CC(CC(C4)C2)C3)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
LMNA P02545 2/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
POLB P06746 1/20 0.51
GAA P10253 1/20 0.51
GFER P55789 1/20 0.51
RARB P10826 6/20 0.50
RARA P10276 5/20 0.50
RARG P13631 4/20 0.50
KDM4E B2RXH2 1/20 0.49
TP53 P04637 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
ALOX12 P18054 1/20 0.49
MAPK1 P28482 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3755595 0.81 MEN1 (0.55) ALDH1A1MEN1KMT2APOLBGAA
SCHEMBL549446 0.80 MEN1 (0.73) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL396121 0.79 MEN1 (0.51) ALDH1A1MEN1KMT2APOLBGAA
SCHEMBL22321006 0.79 MEN1 (0.51) ALDH1A1MEN1KMT2APOLBGAA
SCHEMBL178123 0.79 MEN1 (0.51) ALDH1A1MEN1KMT2APOLBGAA
SCHEMBL25635949 0.79 MEN1 (0.51) ALDH1A1MEN1KMT2APOLBGAA
SCHEMBL566145 0.79 MEN1 (0.51) ALDH1A1MEN1KMT2APOLBGAA
SCHEMBL548836 0.78 MEN1 (0.53) ALDH1A1MEN1KMT2APOLBGAA
SCHEMBL6368048 0.77 ALDH1A1 (0.46) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL548700 0.77 MEN1 (0.52) ALDH1A1MEN1KMT2APOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3044216-B1 NOVEL AND SPECIFIC INHIBITORS OF CYTOCHROME P450 26 RETINOIC ACID HYDROXYLASE UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2022-02-23 EP disclosed